Indian Human Embryonic Stem Cell Technology Granted Patent
Indian medical innovation has come to the forefront with the Human Embryonic Stem Cell technology developed by Dr Geeta Shroff […]
Say something
Tags: Australia, autism, biology, biotechnology, Cell biology, cell therapy, Cerebral palsy, diabetes, Director of Nutech Mediworld, Embryonic stem cell, Geeta Shroff, Geron Corporation, Health/Medical/Pharmaceuticals, healthcare reform, Human Embryonic Stem Cell technology, incurable diseases, India, Israel, Japan, leader, Lyme disease, Malaysia, Medical Director, Multiple Sclerosis, new zealand, Parkinson's disease, ready-to-use product, Singapore, South Korea, Spinal cord injury, spinal injuries, Stem cell, Stem cell controversy, stem cell therapies, stem cell therapy, Stem cell treatments, stem cells, stroke, United States
Cryobanks plans INR 500 cr (US$ 125m) investment
Cryobanks International India(CII), a JV between Cryobanks International Inc of US, and RJ Corp of India, is planning to invest Rs 500 crore in the health care industry in the country over the next five years.
-
-
Flipkart Health+ App Launched
06-04-2022
